371 related articles for article (PubMed ID: 27818323)
1. ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues.
Bayer H; Lang K; Buck E; Higelin J; Barteczko L; Pasquarelli N; Sprissler J; Lucas T; Holzmann K; Demestre M; Lindenberg KS; Danzer KM; Boeckers T; Ludolph AC; Dupuis L; Weydt P; Witting A
Neurobiol Dis; 2017 Jan; 97(Pt A):36-45. PubMed ID: 27818323
[TBL] [Abstract][Full Text] [Related]
2. Decreased mRNA expression of PGC-1α and PGC-1α-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS.
Thau N; Knippenberg S; Körner S; Rath KJ; Dengler R; Petri S
J Neuropathol Exp Neurol; 2012 Dec; 71(12):1064-74. PubMed ID: 23147503
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome Proliferator Activator Receptor Gamma Coactivator-1α Overexpression in Amyotrophic Lateral Sclerosis: A Tale of Two Transgenics.
Varghese M; Zhao W; Trageser KJ; Pasinetti GM
Biomolecules; 2020 May; 10(5):. PubMed ID: 32414179
[TBL] [Abstract][Full Text] [Related]
4. Adipose-derived stem cell exosomes alleviate pathology of amyotrophic lateral sclerosis in vitro.
Lee M; Ban JJ; Kim KY; Jeon GS; Im W; Sung JJ; Kim M
Biochem Biophys Res Commun; 2016 Oct; 479(3):434-439. PubMed ID: 27641665
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs.
Wang L; Yi F; Fu L; Yang J; Wang S; Wang Z; Suzuki K; Sun L; Xu X; Yu Y; Qiao J; Belmonte JCI; Yang Z; Yuan Y; Qu J; Liu GH
Protein Cell; 2017 May; 8(5):365-378. PubMed ID: 28401346
[TBL] [Abstract][Full Text] [Related]
6. Astrocytes drive upregulation of the multidrug resistance transporter ABCB1 (P-Glycoprotein) in endothelial cells of the blood-brain barrier in mutant superoxide dismutase 1-linked amyotrophic lateral sclerosis.
Qosa H; Lichter J; Sarlo M; Markandaiah SS; McAvoy K; Richard JP; Jablonski MR; Maragakis NJ; Pasinelli P; Trotti D
Glia; 2016 Aug; 64(8):1298-313. PubMed ID: 27158936
[TBL] [Abstract][Full Text] [Related]
7. Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis.
Russell AP; Wada S; Vergani L; Hock MB; Lamon S; Léger B; Ushida T; Cartoni R; Wadley GD; Hespel P; Kralli A; Soraru G; Angelini C; Akimoto T
Neurobiol Dis; 2013 Jan; 49():107-17. PubMed ID: 22975021
[TBL] [Abstract][Full Text] [Related]
8. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
[TBL] [Abstract][Full Text] [Related]
9. From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis.
Alrafiah AR
In Vivo; 2018; 32(5):983-998. PubMed ID: 30150420
[TBL] [Abstract][Full Text] [Related]
10. Tetramethylpyrazine nitrone improves motor dysfunction and pathological manifestations by activating the PGC-1α/Nrf2/HO-1 pathway in ALS mice.
Wen J; Li S; Zheng C; Wang F; Luo Y; Wu L; Cao J; Guo B; Yu P; Zhang G; Li S; Sun Y; Yang X; Zhang Z; Wang Y
Neuropharmacology; 2021 Jan; 182():108380. PubMed ID: 33152451
[TBL] [Abstract][Full Text] [Related]
11. The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation.
Liu X; Chen J; Liu W; Li X; Chen Q; Liu T; Gao S; Deng M
Neurogenetics; 2015 Jul; 16(3):223-31. PubMed ID: 25912081
[TBL] [Abstract][Full Text] [Related]
12. A Novel Iron Chelator-Radical Scavenger Ameliorates Motor Dysfunction and Improves Life Span and Mitochondrial Biogenesis in SOD1
Golko-Perez S; Amit T; Bar-Am O; Youdim MB; Weinreb O
Neurotox Res; 2017 Feb; 31(2):230-244. PubMed ID: 27826939
[TBL] [Abstract][Full Text] [Related]
13. ALS-linked FUS exerts a gain of toxic function involving aberrant p38 MAPK activation.
Sama RR; Fallini C; Gatto R; McKeon JE; Song Y; Rotunno MS; Penaranda S; Abdurakhmanov I; Landers JE; Morfini G; Brady ST; Bosco DA
Sci Rep; 2017 Mar; 7(1):115. PubMed ID: 28273913
[TBL] [Abstract][Full Text] [Related]
14. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations.
Bursch F; Kalmbach N; Naujock M; Staege S; Eggenschwiler R; Abo-Rady M; Japtok J; Guo W; Hensel N; Reinhardt P; Boeckers TM; Cantz T; Sterneckert J; Van Den Bosch L; Hermann A; Petri S; Wegner F
Hum Mol Genet; 2019 Sep; 28(17):2835-2850. PubMed ID: 31108504
[TBL] [Abstract][Full Text] [Related]
15. PGC-1α is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis.
Eschbach J; Schwalenstöcker B; Soyal SM; Bayer H; Wiesner D; Akimoto C; Nilsson AC; Birve A; Meyer T; Dupuis L; Danzer KM; Andersen PM; Witting A; Ludolph AC; Patsch W; Weydt P
Hum Mol Genet; 2013 Sep; 22(17):3477-84. PubMed ID: 23669350
[TBL] [Abstract][Full Text] [Related]
16. Elevated PGC-1α activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS.
Da Cruz S; Parone PA; Lopes VS; Lillo C; McAlonis-Downes M; Lee SK; Vetto AP; Petrosyan S; Marsala M; Murphy AN; Williams DS; Spiegelman BM; Cleveland DW
Cell Metab; 2012 May; 15(5):778-86. PubMed ID: 22560226
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective Effect of Human Adipose Stem Cell-Derived Extract in Amyotrophic Lateral Sclerosis.
Jeon GS; Im W; Shim YM; Lee M; Kim MJ; Hong YH; Seong SY; Kim M; Sung JJ
Neurochem Res; 2016 Apr; 41(4):913-23. PubMed ID: 26646002
[TBL] [Abstract][Full Text] [Related]
18. PGC-1α protects neurons and alters disease progression in an amyotrophic lateral sclerosis mouse model.
Liang H; Ward WF; Jang YC; Bhattacharya A; Bokov AF; Li Y; Jernigan A; Richardson A; Van Remmen H
Muscle Nerve; 2011 Dec; 44(6):947-56. PubMed ID: 22102466
[TBL] [Abstract][Full Text] [Related]
19. Directly converted patient-specific induced neurons mirror the neuropathology of FUS with disrupted nuclear localization in amyotrophic lateral sclerosis.
Lim SM; Choi WJ; Oh KW; Xue Y; Choi JY; Kim SH; Nahm M; Kim YE; Lee J; Noh MY; Lee S; Hwang S; Ki CS; Fu XD; Kim SH
Mol Neurodegener; 2016 Jan; 11():8. PubMed ID: 26795035
[TBL] [Abstract][Full Text] [Related]
20. [Development of motor neuron restorative therapy in amyotrophic lateral sclerosis using hepatocyte growth factor].
Aoki M; Warita H; Suzuki N; Itoyama Y
Rinsho Shinkeigaku; 2009 Nov; 49(11):814-7. PubMed ID: 20030218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
